Clinical Trials Browser

Carcinoma, Ductal, Breast

NCT00470236 2023-03-22

DCIS

Phase NA Unknown

1,608 enrolled

Breast

Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Ductal, Breast

NCT02983071 2023-02-15

G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer

Phase 1/2 Unknown

102 enrolled

Breast

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT03749850 2021-02-17

i-GO

Phase 1 Unknown

12 enrolled

Breast

Hyperthermia, Breast Neoplasms, Neoplasm Metastasis, Carcinoma, Ductal, Breast

NCT02879513 2020-03-23

Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy

Phase 3 Unknown

290 enrolled

Breast

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT04021069 2019-07-16

Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer

Unknown

800 enrolled

Breast

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular

NCT00814567 2019-02-27

IMPORT

Phase NA Unknown

2,018 enrolled

Breast

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT00723294 2017-08-14

Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer

Phase 2 Unknown

99 enrolled 4 charts

Breast

Breast Neoplasms, Carcinoma, Ductal, Breast, Breast Neoplasms, Male

NCT00967239 2015-05-08

Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2

Unknown

1,881 enrolled

Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Ductal, Breast, Carcinoma, Lobular

NCT00602316 2013-08-26

Multifunctional Magnetic Resonance Imaging in Predicting Breast Lesions in Women Undergoing Mastectomy for Breast Cancer

Phase NA Unknown

20 enrolled

Breast

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT01484704 2011-12-02

The Significance of MRI in the Development of Diagnostics and Treatment of Breast Cancer

Unknown

100 enrolled

Breast

Carcinoma, Ductal, Breast

NCT01126138 2011-05-04

Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)

Phase 3 Unknown

200 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis, Carcinoma, Ductal, Breast

Clinical Trials

Effect of Ultrasound Combined With Microbubbles on Blood Perfusion in Invasive Breast Cancer

DCIS

G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer

i-GO

Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy

Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer

IMPORT

Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer

Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2

Multifunctional Magnetic Resonance Imaging in Predicting Breast Lesions in Women Undergoing Mastectomy for Breast Cancer

The Significance of MRI in the Development of Diagnostics and Treatment of Breast Cancer

Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)